Literature DB >> 28364163

Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances.

Sandip Basu1,2, Sharmila Banerjee3,4.   

Abstract

Mesh：

Year:  2017        PMID： 28364163     DOI： 10.1007/s00259-017-3686-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  7 in total

Review 1.  Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.

Authors:  D Scott Wilbur
Journal:  Curr Radiopharm       Date:  2011-07

2.  Developing a dedicated comprehensive α-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade?

Authors:  Sandip Basu; Sharmila Banerjee
Journal:  Nucl Med Commun       Date:  2017-02       Impact factor: 1.690

3.  Targeted α-Based Treatment of Metastatic Castration-Resistant Prostate Cancer: Revolutionizing Systemic Radiotherapy?

Authors:  Wim J G Oyen; Johann S de Bono
Journal:  J Nucl Med       Date:  2016-08-18       Impact factor: 10.057

4.  (211)At-labeled agents for alpha-immunotherapy: On the in vivo stability of astatine-agent bonds.

Authors:  Tahra Ayed; Julien Pilmé; David Tézé; Fadel Bassal; Jacques Barbet; Michel Chérel; Julie Champion; Rémi Maurice; Gilles Montavon; Nicolas Galland
Journal:  Eur J Med Chem       Date:  2016-03-29       Impact factor: 6.514

5.  Targeted alpha therapy: part I.

Authors:  Jorgen Elgqvist
Journal:  Curr Radiopharm       Date:  2011-07

Review 6.  Optimizing radioimmunoconjugate delivery in the treatment of solid tumor.

Authors:  Chen-Yu Huang; Mohammad H Pourgholami; Barry J Allen
Journal:  Cancer Treat Rev       Date:  2012-01-04       Impact factor: 12.111

Review 7.  Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle.

Authors:  Yana Dekempeneer; Marleen Keyaerts; Ahmet Krasniqi; Janik Puttemans; Serge Muyldermans; Tony Lahoutte; Matthias D'huyvetter; Nick Devoogdt
Journal:  Expert Opin Biol Ther       Date:  2016-05-19       Impact factor: 4.388
  7 in total
  1 in total

Review 1.  Progress in Targeted Alpha-Particle Therapy. What We Learned about Recoils Release from In Vivo Generators.

Authors:  Ján Kozempel; Olga Mokhodoeva; Martin Vlk
Journal:  Molecules       Date:  2018-03-05       Impact factor: 4.411
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.